BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38635246)

  • 1. Estrogen-Only Hormone Therapy and Dementia.
    Wood Alexander M; Einstein G; Rabin JS
    JAMA; 2024 May; 331(18):1593-1594. PubMed ID: 38635246
    [No Abstract]   [Full Text] [Related]  

  • 2. Estrogen-Only Hormone Therapy and Dementia-Reply.
    Pourhadi N; Mørch LS; Meaidi A
    JAMA; 2024 May; 331(18):1594-1596. PubMed ID: 38635226
    [No Abstract]   [Full Text] [Related]  

  • 3. Estrogen-Only Hormone Therapy and Dementia.
    Glynne S
    JAMA; 2024 May; 331(18):1594. PubMed ID: 38635242
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.
    Kuller LH
    J Natl Cancer Inst; 2000 Jul; 92(13):1100-1. PubMed ID: 10880556
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of reproductive factors and postmenopausal hormone use on the risk of Parkinson disease.
    Popat RA; Van Den Eeden SK; Tanner CM; McGuire V; Bernstein AL; Bloch DA; Leimpeter A; Nelson LM
    Neurology; 2005 Aug; 65(3):383-90. PubMed ID: 16087902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular and metabolic effects of medroxyprogesterone acetate versus conjugated equine estrogen after premenopausal hysterectomy with bilateral ovariectomy.
    Kalyan S; Hitchcock CL; Sirrs S; Pudek M; Prior JC
    Pharmacotherapy; 2010 May; 30(5):442-52. PubMed ID: 20411996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risks and benefits of hormone therapy after menopause for cognitive decline and dementia: A conceptual review.
    Rocca WA; Kantarci K; Faubion SS
    Maturitas; 2024 Jun; 184():108003. PubMed ID: 38649310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive changes after menopause: influence of estrogen.
    Henderson VW
    Clin Obstet Gynecol; 2008 Sep; 51(3):618-26. PubMed ID: 18677155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive decline and dementia in women after menopause: Prevention strategies.
    Stefanowski B; Kucharski M; Szeliga A; Snopek M; Kostrzak A; Smolarczyk R; Maciejewska-Jeske M; Duszewska A; Niwczyk O; Drozd S; Englert-Golon M; Smolarczyk K; Meczekalski B
    Maturitas; 2023 Feb; 168():53-61. PubMed ID: 36493633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Women: US Preventive Services Task Force Recommendation Statement.
    ; Grossman DC; Curry SJ; Owens DK; Barry MJ; Davidson KW; Doubeni CA; Epling JW; Kemper AR; Krist AH; Kurth AE; Landefeld CS; Mangione CM; Phipps MG; Silverstein M; Simon MA; Tseng CW
    JAMA; 2017 Dec; 318(22):2224-2233. PubMed ID: 29234814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hormone substitution therapy in menopause and risk of breast cancer].
    Colin C
    Rev Fr Gynecol Obstet; 1991 Jan; 86(1):27-8. PubMed ID: 2068481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogens in postmenopausal women: recent insights.
    Constantine GD; Pickar JH
    Curr Opin Pharmacol; 2003 Dec; 3(6):626-34. PubMed ID: 14644015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen therapy in gynecological cancer survivors.
    Guidozzi F
    Climacteric; 2013 Dec; 16(6):611-7. PubMed ID: 23952524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Options for hormone therapy in women who have had a hysterectomy.
    Haney AF; Wild RA
    Menopause; 2007; 14(3 Pt 2):592-7; quiz 598-9. PubMed ID: 17476150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone-replacement therapy. Weighing the benefits and risks.
    Harv Health Lett; 1997 Oct; 22(12):1-3. PubMed ID: 9674386
    [No Abstract]   [Full Text] [Related]  

  • 16. Race, Menopausal Hormone Therapy, and Invasive Breast Cancer in the Carolina Breast Cancer Study.
    DeBono NL; Robinson WR; Lund JL; Tse CK; Moorman PG; Olshan AF; Troester MA
    J Womens Health (Larchmt); 2018 Mar; 27(3):377-386. PubMed ID: 28570827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of estrogen/androgen therapy. Menopausal symptoms, bone, and cardiovascular parameters.
    Barrett-Connor E
    J Reprod Med; 1998 Aug; 43(8 Suppl):746-52. PubMed ID: 9750204
    [No Abstract]   [Full Text] [Related]  

  • 18. Menopause: a normal view.
    Voda AM
    Clin Obstet Gynecol; 1992 Dec; 35(4):923-33. PubMed ID: 1451375
    [No Abstract]   [Full Text] [Related]  

  • 19. Hormone replacement therapy and ovarian cancer risk--any news?
    Riman T
    Acta Obstet Gynecol Scand; 2007; 86(9):1032-4. PubMed ID: 17712640
    [No Abstract]   [Full Text] [Related]  

  • 20. Hormone therapy and the impact of estrogen intake on the risk of ovarian cancer.
    Glud E; Kjaer SK; Thomsen BL; Høgdall C; Christensen L; Høgdall E; Bock JE; Blaakaer J
    Arch Intern Med; 2004 Nov; 164(20):2253-9. PubMed ID: 15534163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.